Alyeska Investment Group’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $40.7M | Sell |
2,430,458
-795,155
| -25% | -$13.3M | 0.14% | 180 |
|
|
2025
Q1 | $49.6M | Sell |
3,225,613
-415,779
| -11% | -$6.39M | 0.2% | 143 |
|
|
2024
Q4 | $80.3M | Buy |
3,641,392
+16,392
| +0.5% | +$361K | 0.3% | 81 |
|
|
2024
Q3 | $65.3M | Sell |
3,625,000
-203,871
| -5% | -$3.67M | 0.33% | 102 |
|
|
2024
Q2 | $62.2M | Sell |
3,828,871
-2,516,937
| -40% | -$40.9M | 0.36% | 92 |
|
|
2024
Q1 | $89.5M | Buy |
6,345,808
+886,499
| +16% | +$12.5M | 0.55% | 50 |
|
|
2023
Q4 | $57M | Sell |
5,459,309
-1,003,267
| -16% | -$10.5M | 0.38% | 81 |
|
|
2023
Q3 | $65.9M | Buy |
6,462,576
+4,962,576
| +331% | +$50.6M | 0.45% | 71 |
|
|
2023
Q2 | $11.3M | Buy |
1,500,000
+700,000
| +88% | +$5.27M | 0.08% | 249 |
|
|
2023
Q1 | $7.08M | Buy |
+800,000
| New | +$7.08M | 0.06% | 275 |
|
|
2016
Q2 | – | Sell |
-334,318
| Closed | -$17.9M | – | 487 |
|
|
2016
Q1 | $17.9M | Sell |
334,318
-1,090,927
| -77% | -$58.4M | 0.16% | 188 |
|
|
2015
Q4 | $93.6M | Buy |
1,425,245
+1,400,730
| +5,714% | +$91.9M | 0.99% | 12 |
|
|
2015
Q3 | $1.38M | Buy |
+24,515
| New | +$1.38M | 0.02% | 358 |
|
|
2015
Q2 | – | Sell |
-579,879
| Closed | -$36.1M | – | 548 |
|
|
2015
Q1 | $36.1M | Buy |
+579,879
| New | +$36.1M | 0.5% | 45 |
|
|
2014
Q3 | – | Sell |
-231,640
| Closed | -$12.1M | – | 424 |
|
|
2014
Q2 | $12.1M | Sell |
231,640
-143,360
| -38% | -$7.52M | 0.27% | 115 |
|
|
2014
Q1 | $19.8M | Buy |
+375,000
| New | +$19.8M | 0.54% | 41 |
|